ITMI941694A0 - HYBRID MOLECULES FOR ANTICANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS - Google Patents

HYBRID MOLECULES FOR ANTICANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

Info

Publication number
ITMI941694A0
ITMI941694A0 ITMI941694A ITMI941694A ITMI941694A0 IT MI941694 A0 ITMI941694 A0 IT MI941694A0 IT MI941694 A ITMI941694 A IT MI941694A IT MI941694 A ITMI941694 A IT MI941694A IT MI941694 A0 ITMI941694 A0 IT MI941694A0
Authority
IT
Italy
Prior art keywords
preparation
pharmaceutical compositions
hybrid molecules
anticancer treatment
anticancer
Prior art date
Application number
ITMI941694A
Other languages
Italian (it)
Inventor
Antonio Mele
Luigi Rotondaro
Loreto Mario Di
Alatri Laura D
Original Assignee
Menarini Ricerche Sud Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Sud Spa filed Critical Menarini Ricerche Sud Spa
Priority to ITMI941694A priority Critical patent/IT1271688B/en
Publication of ITMI941694A0 publication Critical patent/ITMI941694A0/en
Priority to AU32552/95A priority patent/AU3255295A/en
Priority to PCT/EP1995/003060 priority patent/WO1996004305A1/en
Publication of ITMI941694A1 publication Critical patent/ITMI941694A1/en
Application granted granted Critical
Publication of IT1271688B publication Critical patent/IT1271688B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
ITMI941694A 1994-08-04 1994-08-04 HYBRID MOLECULES FOR ANTI-CANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS IT1271688B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI941694A IT1271688B (en) 1994-08-04 1994-08-04 HYBRID MOLECULES FOR ANTI-CANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
AU32552/95A AU3255295A (en) 1994-08-04 1995-08-01 Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
PCT/EP1995/003060 WO1996004305A1 (en) 1994-08-04 1995-08-01 Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941694A IT1271688B (en) 1994-08-04 1994-08-04 HYBRID MOLECULES FOR ANTI-CANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

Publications (3)

Publication Number Publication Date
ITMI941694A0 true ITMI941694A0 (en) 1994-08-04
ITMI941694A1 ITMI941694A1 (en) 1996-02-04
IT1271688B IT1271688B (en) 1997-06-04

Family

ID=11369444

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941694A IT1271688B (en) 1994-08-04 1994-08-04 HYBRID MOLECULES FOR ANTI-CANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

Country Status (3)

Country Link
AU (1) AU3255295A (en)
IT (1) IT1271688B (en)
WO (1) WO1996004305A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019157A1 (en) * 2000-04-18 2001-11-15 Stefan Duebel Method for introducing ligands into living cells
CZ20033119A3 (en) 2001-04-24 2005-01-12 Merck Patent Gmbh Combination therapy using anti-angiogenic agents and TNF alpha
EA016817B1 (en) 2006-01-18 2012-07-30 Мерк Патент Гмбх Specific therapy using integrin ligands for treating cancer
KR20090108713A (en) 2007-01-18 2009-10-16 메르크 파텐트 게엠베하 Specific therapy and medicament using integrin ligands for treating cancer
KR20120104491A (en) 2009-05-25 2012-09-21 메르크 파텐트 게엠베하 Continuous administration of cilengitide in cancer treatments
EP2593122A1 (en) 2010-07-16 2013-05-22 Merck Patent GmbH Peptide for use in the treatment of breast cancer and/or bone metastases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
JPH05502463A (en) * 1990-09-28 1993-04-28 オーソ・フアーマシユーチカル・コーポレーシヨン hybrid growth factor
EP0574395B1 (en) * 1990-11-09 2002-06-12 GILLIES, Stephen D. Cytokine immunoconjugates

Also Published As

Publication number Publication date
ITMI941694A1 (en) 1996-02-04
WO1996004305A1 (en) 1996-02-15
AU3255295A (en) 1996-03-04
IT1271688B (en) 1997-06-04

Similar Documents

Publication Publication Date Title
ITMI942025A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ENGINEERED MICROORGANISMS AND THEIR USE FOR THERAPY
ITMI950529A0 (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION
EE03399B1 (en) Spiro-azabicyclic compounds used in therapy and process for their preparation
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
EE9900075A (en) 7α- (-aminoalkyl) oestratrienes, process for their preparation, pharmaceutical preparations containing 7α- (-aminoalkyl) oestratrienes and their use in the manufacture of medicaments
EE9700020A (en) Heteroatom-containing cyclopentanepyridyloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE9700145A (en) Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds
EE04965B1 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents, their use in the preparation of pharmaceuticals and pharmaceutical composition
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
IL116154A0 (en) Perhydroisoindole derivatives their preparation and pharmaceutical compositions containing the same
ITMI941446A0 (en) ESCULOSIDE-BASED FORMULATIONS AND THEIR USE IN THE PHARMACEUTICAL AND COSMETIC FIELD
EE9900112A (en) 2-Cyanoiminoimidazole derivatives, process for their preparation, use and pharmaceutical compositions
HUP9904027A3 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
EE9900155A (en) 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, process for their preparation and use in therapy
EE9700288A (en) Azacycloalkane derivatives, their preparation and use in therapy
AU3986097A (en) Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
EE04371B1 (en) Phenylamidine derivatives, processes for their preparation and their use in medicine
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
ITMI941694A0 (en) HYBRID MOLECULES FOR ANTICANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
IL127304A (en) Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression
FI940186A (en) 9H-Imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their use in therapy
DE69520870D1 (en) Esculetin derivatives, process for their preparation and pharmaceutical composition
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
IL164513A0 (en) Pyrazolopyrimidines, pharmaceutical compositions containing them, and their use in the preparation of medicaments

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970828